## Edrophonium: Pharmacokinetics and Clinical Use **Key Point:** Edrophonium is a **reversible, competitive inhibitor** of acetylcholinesterase with an **onset of 30–60 seconds** and a **duration of only 5–10 minutes**, making it ideal for diagnostic testing (Tensilon test) in myasthenia gravis. ### Mechanism of Rapid Onset and Offset 1. **Reversible binding** — edrophonium forms weak, transient electrostatic interactions with the anionic site of acetylcholinesterase 2. **Rapid renal excretion** — as a quaternary ammonium compound, edrophonium is highly hydrophilic and is filtered and excreted unchanged by the kidneys within minutes 3. **No metabolism** — minimal hepatic or plasma metabolism means kinetics are determined purely by renal clearance ### Comparison with Other Anticholinesterases | Drug | Reversibility | Onset | Duration | Route of Elimination | |------|---------------|-------|----------|----------------------| | **Edrophonium** | Reversible | 30–60 sec | 5–10 min | Renal (quaternary amine) | | **Neostigmine** | Reversible (carbamate) | 7–15 min | 30–60 min | Renal + hydrolysis | | **Physostigmine** | Reversible (carbamate) | 3–8 min | 30–60 min | Hepatic metabolism | | **Pralidoxime** | Reactivator (not inhibitor) | 1 min | 1–2 hrs | Renal | **High-Yield:** The **Tensilon test** relies on edrophonium's ultra-short duration: if the patient has myasthenia gravis, acetylcholine accumulation will transiently improve muscle strength within seconds; the effect wears off within 5–10 minutes, allowing safe reversal with atropine if needed. **Clinical Pearl:** Edrophonium is now rarely used in clinical practice (largely replaced by serology and electromyography) but remains a high-yield concept for NEET PG because it illustrates the relationship between reversibility, ionization, and renal clearance. **Mnemonic:** **REDO** — **R**eversible, **E**drophonium, **D**iagnostic, **O**nset rapid. [cite:KD Tripathi 8e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.